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ABSTRACT
Immune function measured by Staphylococcus
aureus- and phytohemagglutinin- (PHA-) induced cell
proliferationwas assessed in a population of 445 geneti-
cally deﬁned, F2 and backcross Charolais-Holstein
crossbred cattle when the animals were approximately
5 mo of age. Variation in Staph. aureus-induced, PHA-
induced, and control proliferation [peripheral blood
mononuclear cell (PBMC) andmedia only]was observed
at d 2, 3, 4, 5, 9, and 10 of in vitro culture. The levels
of Staph. aureus-induced, PHA-induced, and control
proliferation were strongly positively correlated be-
tween days of culture within-assay (e.g., between d 2
and d 3 or between d 4 and d 5). Responses were also
positively correlated when the same individuals were
resampled and the assay repeated within 3 mo. Analy-
ses ﬁtting linear mixed models using REML showed
thatStaph. aureus-induced andPHA-induced prolifera-
tion was signiﬁcantly associated with control prolifera-
tion and the year of birth. The age of the animal at
sampling inﬂuenced only Staph. aureus-induced prolif-
eration, with Staph. aureus-induced proliferation in-
creasing with the age of the animal. Control prolifera-
tion was inﬂuenced by a sex × cross interaction, al-
though in this study, sex was confounded by
management, as female cattle were housed and reared
differently from male cattle. All 3 measures of immune
function were inﬂuenced by sire, demonstrating that
these traits are partially under genetic control, and
indicating that it may ultimately be possible to identify
quantitative trait loci for these measures of immunity.
(Key words: crossbred, restricted maximum likeli-
hood, Staphylococcus aureus, peripheral bloodmononu-
clear cell)
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patibility complex, PBMC = peripheral blood mononu-
clear cell, PHA = phytohemagglutinin.
INTRODUCTION
Bovine mastitis remains a major problem to both the
dairy (Bradley, 2002) and beef industries (Simpson et
al., 1995). In the dairy industry, mastitis affects the
quality and quantity of milk and has been identiﬁed as
one of the most signiﬁcant causes of economic loss to
this agricultural sector worldwide (De Graves and Fe-
trow, 1993). Studies in dairy cattle have shown that
approximately 25% of cows within UK herds are af-
fected by clinical mastitis at any one time (Kossaibati
et al., 1998). Incidence of mastitis has been reported
to be between 20 and 40 cases per cow-year within
European herds (Heringstad et al., 2000), and 30 to 37
cases per cow-year within herds in the United States
(Gardner et al., 1990; Kaneene and Hurd, 1990; Miller
and Dorn, 1990). In the United Kingdom, subclinical
disease, of which Staphylococcus aureus is the predomi-
nant cause (Wilson and Richards, 1980), has been
shown to account for a reduction in milk yield of be-
tween 2.5 and 6.5% (Wood and Booth, 1983) and results
in premature culling and considerable economic loss.
In beef cattle, several studies have highlighted an asso-
ciation between intramammary infections and reduced
weight gain in calves (Haggard et al., 1983; Newman
et al., 1991). In a study involving more than 300 beef
cows, 37% of cows and 18.1% of quarters had intramam-
mary infections, and SCC were negatively correlated
with calf weaning weights (Watts et al., 1986). How-
ever, as extensive management practices are used in
rearing beef cattle, there is reduced opportunity for
diagnosis of mastitis, and thus, disease incidence may
be considerably underestimated in these cows. In beef
and dairy cattle, pathogens other than Staph. aureus
can be responsible for causing mastitis, with Esche-
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richia coli, Streptococcus uberis, and Streptococcus dys-
galactiae the most prevalent in the UK (Wilesmith et
al., 1986; Watts et al., 1986).
Breeding for resistance tomammary gland pathogens
has the potential to complement traditional therapeutic
and prophylacticmeasures formastitis, which have had
limited success in controlling disease (Detilleux, 2002).
Genetic variation in dairy cattle associated with resis-
tance to mastitis was ﬁrst reviewed in the 1950s (Leg-
ates and Grinnells, 1952); however, direct selection of
animals for resistance to mastitis has been hampered
by the lack of accurate ﬁeld recording of disease inci-
dence, especially for clinical disease (Mrode et al., 1998).
Optimal protection from disease undoubtedly involves
many genes and will involve the coordination of aspects
of both the innate and acquired immune systems (Malo
and Skamene, 1994; Sordillo et al., 1997). In terms of
resistance to bovine mastitis, the mammary gland has
many forms of defense against invasion by pathogenic
organisms, combining nonspeciﬁc and speciﬁc systems,
including anatomical features of the gland and humeral
and cellular defense mechanisms (Outteridge and Lee,
1988). In addition, the physiological status of the indi-
vidual, i.e., pregnancy, puberty, or lactation, has a ma-
jor inﬂuence on the immune response within the mam-
mary gland (Kelm et al., 2001).
Neutrophils, macrophages, lymphocytes, and epithe-
lial cells are normally found in mammary secretions,
with the numbers and proportions of these cells varying
among individuals and altering throughout lactation
(Lee et al., 1980). In spite of the presence of considerable
numbers of immune cells within the local mammary
gland environment, it has been shown that the mam-
mary gland is generally immunologically compromised
compared with systemic responses (Hurley et al., 1990).
Indiscriminate ingestion of fat, casein, and other milk
components results in less effective phagocytosis by
mammary neutrophils and macrophages compared
with blood leukocytes (Paape et al., 1981). Therefore,
recruitment of cells such as neutrophils from the blood
is essential to the defense of themammary gland (Smits
et al., 2000; Paape et al., 2003). Once at the site of
infection, neutrophils phagocytose and kill bacterial
pathogens (Sordillo et al., 1997). Staphylococci use a
number of mechanisms to avoid phagocytosis by invad-
ing deep into the mammary gland where they survive
and multiply within host phagocytic cells (Sandholm
and Mattila, 1986), including neutrophils. Lympho-
cytes are also critical for host immunity as they respond
to infectious agents through elaboration of antibodies,
cytokines, and through speciﬁc T-cell immunity (Detil-
leux et al., 1994) and therefore play an essential role
in the control of pathogenic invasion of the mammary
gland (Kehrli and Goff, 1989). In the mammary gland,
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both innate and acquired protective factors are coordi-
nated to provide optimal protection from disease (Sor-
dillo et al., 1997) and it is important that both arms
of the immune response are considered in selection of
future generations of dairy cattle.
Induction of a proliferative response induced by anti-
gen in vitro has been shown to be representative of
cellular immunocompetence (Kristensson et al., 1994)
and previous studies have shown variation in Staph.
aureus-induced proliferative response among commer-
cial Holstein-Friesian cattle, measured by 3H-thymi-
dine incorporation in the responding peripheral blood
mononuclear cell (PBMC) population (Fitzpatrick et
al., 1999; Logan 2001). This measure could potentially
be used as an indicator of an individual’s ability to
mount an immune response to speciﬁc pathogens. Vari-
ation in individual animals in the T-cell proliferative
response to FMDV peptide has been reported (Glass et
al., 2000) and additionally, other studies have identiﬁed
variation among individual cattle in the levels of in
vitro PBMC blastogenesis induced by lectins (Pearson
et al., 1979; Schore et al., 1981; Rivas et al., 2002) as
a measure of nonspeciﬁc immune function. Studies in
many species including humans (Hall et al., 2000), mice
(Stiffel et al., 1977), chickens (Cheng et al., 1991), and
pigs (Wilkie and Mallard, 1999) have investigated the
genetic control of immune function, and heritabilities
have been reported for PBMC proliferation in lactating
dairy cattle when induced by concanavalin A (Kehrli
et al., 1991), and in pigs when induced by concanavalin
A (Edfors-Lilja et al., 1994) and phytohemagglutinin
(PHA; Jensen and Christensen, 1981).
The current study examines the extent of genetic
variation for in vitro proliferative response in a large,
cross-bred, genetically diverse population that had the
potential for widely differing exposures and immune
responses to pathogens, in contrast to studies of pure-
bred dairy (Weigel et al., 1991; Detilleux et al., 1995)
or beef cattle. Although it could be argued that the
measurement of such proliferative responses has only
some of the desirable characteristics for implementa-
tion (e.g., easily measured, preferably in both sexes at
a young age), the existence or otherwise of genetic varia-
tion in such traits guides the search for QTL of immune
function. SuchQTL could be exploitedmuchmore easily
than measures of immune function in breeding pro-
grams to improve livestock production and animal wel-
fare. The results relating to PBMC are presented here;
neutrophil responses will be the subject of an addi-
tional report.
MATERIALS AND METHODS
Animals
The study populationwas aherd of second-generation
Charolais × Holstein cattle bred at the Roslin Institute
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to identify potential QTL associated with commercially
relevant production traits in cattle includingmeat qual-
ity, growth rate, carcass development, and fertility. The
herd included 89 Holstein dam backcross, 77 Charolais
sire backcross, and 279 Holstein × Charolais second-
cross animals (F2). The progeny were produced using
8 F1 sires (identiﬁed as A, B, C, D, E, F, G, and H) and
4 F0 Charolais sires (identiﬁed as W, X, Y, and Z).
Management
Four hundred forty-ﬁve second-generation crossbred
cattle were born and sampled over 4 yr: 55 in 1998, 117
in 1999, 134 in 2000, and 139 in 2001. Male calves (n =
236) and female calves (n = 209) were reared under
different management systems. Male calves were
reared outdoors on pasture with their dams until ap-
proximately 5 mo of age, whereas female calves were
removed from their dams within 24 h of birth, housed,
and fed milk-replacer. At approximately 5 mo of age,
males were weaned from their mothers and housed.
Animals were housed in single sex groups, of similar
weight. The weight of each animal was monitored
throughout the duration of the project and animalswere
regrouped periodically into similar weight-matched
groups. Male calves were slaughtered at approximately
550 kg and production factors including carcass compo-
sition and weight gain were assessed.
Sampling
Batches of approximately 16 animals per week were
blood sampled; 20 mL of anticoagulated (heparin Vacu-
tainer, 143 USP units, Becton Dickinson, Oxford, UK)
blood was collected aseptically from each animal by
jugular venipuncture. For management ease and ani-
mal handling, test batches were group-based, and thus,
the animals sampled within a batch were of a similar
weight. Blood samples were processed within 2 h of col-
lection.
The repeatability of the test was assessed by the re-
peated sampling of 35% of the animals, chosen at ran-
dom, within approximately 3 mo of the initial sampling
in each of the ﬁrst 3 yr. This was deﬁned as test 2,
with test 1 being the initial sampling of all animals
described above.
PBMC Proliferation Assay
Proliferation of PBMCwasmeasured in vitro. Brieﬂy,
the sample was diluted with 10 mL of Hanks’ balanced
salt solution without calcium or magnesium (HBSS;
Sigma Ltd., Poole, UK), underlaid with 20 mL of Histo-
paque 1077 (Sigma), and centrifuged at 700 × g for 40
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min at 20°C. Following centrifugation, the PBMC layer
was removed and diluted with HBSS to give a ﬁnal
volume of 50 mL. Following centrifugation at 400 × g
for 10 min at 20°C, the supernatant was discarded and
the cell pellet was resuspended in HBSS. This wash
step was repeated 3 more times. Finally, the superna-
tant was discarded and the cell pellet was resuspended
in basal medium Eagles (BME, Gibco Life Technologies
Ltd., Paisley, UK). One milliliter of PBMC suspension
(4.0 × 106 cells) and 1mL of either formalin-ﬁxed Staph.
aureus strain NCTC13047 (2.0 × 108 cells), medium, or
PHA (5 μg/mL, Sigma), and 40 μL of heat-inactivated
autologous serum were added and incubated at 37°C
with 5% CO2 over a 10-d period. Autologous serum was
used throughout because preliminary investigations
showed that background levels of proliferation in the
absence of antigen were lower with autologous serum
than with commercial fetal calf serum.
On d 2, 3, 4, 5, 9, and 10 of culture, 100-μL aliquots
were removed in triplicate into 96-well round-bottomed
plates (Bibby Sterilin, Staffordshire, UK), and pulsed
with 1 μCi of 3H-thymidine per well (Amersham Phar-
macia Biotech UK Limited, Amersham, UK) at 37°C
with 5% CO2 for 6 h. Following incubation, the 96-
well plates were removed and stored at −20°C until
harvesting. Cells were harvested onto the ﬁlter plates
from the 96-well plates using a Filtermat 196 Cell Har-
vester (Canberra Packard Ltd., Berkshire, UK). The
harvested cells were washed to remove unincorporated
3H-thymidine, and 20 μL of scintillation ﬂuid was
added. The radioactivity incorporated into theDNAwas
trapped on the ﬁlter, and determined using a Topcount
Microplate scintillation and luminescence counter
(Canberra Packard). Results were expressed as counts
per minute of 3H-thymidine incorporation (mean of the
triplicates). For the 2001 cohort, the proliferation of
PBMC was assessed on d 4 of culture only, a choice
that is justiﬁed later in this paper.
Statistical Methods
Preliminary analyses of all raw data used procedures
to determine the optimum Box and Cox transformation
of the data (Box and Cox, 1964; Minitab, Release 13,
Minitab Ltd., UK). This procedure identiﬁed logarith-
mic transformation as optimal. In addition, the prelimi-
nary analyses identiﬁed that the regression coefﬁcient
for control proliferation was not equal to one, on neither
the observed scale nor the logarithmic scale. This indi-
cated that the use of change in counts per minute or
stimulation indices in the analyses would have been
inappropriate. Therefore, the control proliferation of
PBMC in vitro for each individual animal was retained
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within the model as a covariate as described later, and
was additionally analyzed as a separate Y-variate.
Linear mixed models were ﬁtted to the natural loga-
rithm of the data using REML procedures in Genstat
(6th ed., Lawes Agricultural Trust, Rothamsted, UK).
The Y variates analyzed were 1) Staph. aureus-induced
PBMC proliferation, 2) PHA-induced PBMC prolifera-
tion, and 3) control PBMC proliferation. The linear
model was:
Yijkmnp = μ + αi + βj + γk + δm + κ(cijkmnp − cˆ)
+ φ(sijkmnp − sˆ) + un + eijkmnp
for calf p, with sire n, of sex i, breed-cross j, born in
year k, sampled in batch m, with control proliferation
cijkmnp, and age sijkmnp at time of sampling, with cˆ and
sˆ representing themean control proliferation andmean
age of all calves, respectively; where μ is the ﬁtted
mean, αi is the effect of sex (male and female; i = 1,2),
βj is the effect of breed-cross (Holstein dam backcross,
F2, and Charolais sire backcross; j = 1,...3), γk is the
effect of year of birth (k = 1,...4), δm is batch of sampling
(m = 1,...34), and where κ and φ are the partial regres-
sion coefﬁcients for control proliferation (on a natural
logarithm scale) and age at sampling (days), respec-
tively. The regression on control proliferation was omit-
ted when it was itself the Y-variate. The random terms
un and eijkmnp represent the effects of sire n and the
residual error respectively, assumed to have univariate
normal distributions with mean 0 and variances σ2s,
and σ2e, respectively.
Initial models considered all 2-way interactions be-
tween the ﬁxed effects, but only those that achieved
statistical signiﬁcance (P < 0.05) were retained. Using
this approach, the only interaction included in themod-
els was the interaction between sex and cross in the
model for control proliferation as a Y-variate. Treating
the sampling batch as a random factor, rather than
ﬁxed was considered, but examination of the ﬁtted val-
ues suggested nonrandom trends within years.
The signiﬁcance of ﬁxed effects in the model was
determined using the Wald test (Wald, 1947). The sig-
niﬁcance of randomeffects in themodelwas determined
from log likelihood ratio tests. Heritabilities were calcu-
lated using h2 = 4
σ2s
σ2p
where the phenotypic variance
σ2p was estimated as σ2p = σ2s + σ2e.
Preliminary analyses examined the proﬁles and rela-
tionships between days but detailed results of the
REML analyses for PBMC proliferation induced by
Staph. aureus, PHA, and control are presented for d
4 only.
Journal of Dairy Science Vol. 88, No. 7, 2005
Figure 1.Kinetics ofStaphylococcus aureus-induced (), phytohe-
magglutinin-induced (), and control () in vitro peripheral blood
mononuclear cell proliferation (cpm ± SEM) over 10 d of culture (1998,
1999, and 2000 cohorts).
RESULTS
Kinetics of PBMC Proliferation
The kinetics for Staph. aureus-induced, PHA-in-
duced, and control PBMC proliferation are shown in
Figure 1. Considerable variation in Staph. aureus-
induced, PHA-induced, and control proliferation of
PBMC in vitro was observed among individual animals
as indicated by the error bars included in the ﬁgure
(± SEM). Staphylococcus aureus-induced proliferation
was found to peak at d 5 of culture, whereas PHA-
induced proliferation was found to peak earlier, at d 3.
The largest variation among individual animals was
observed on the days of maximal proliferation in Staph.
aureus- and PHA-induced cultures. Mean (± SEM)
Staph. aureus-induced proliferation was 25,835 ± 1890
cpmon d 5 of culture, and themean PHA-induced prolif-
eration was 46,248 ± 1886 cpm on d 3 of culture. By d
9, both Staph. aureus- and PHA-induced proliferation
had declined to similar levels as the control. Control
proliferation remained relatively low throughout the
duration of culture; mean (± SEM) proliferation on d
3 and 5 of culture were 1436 ± 144 and 730 ± 102
cpm, respectively.
For each of the cultures (i.e., Staph. aureus-induced,
PHA-induced, and control), observations of individual
time points within the assay were positively correlated.
The results for Staph. aureus-induced proliferation are
shown in Figure 2. Correlations for each culture were
strong amongmeasurements taken on d 2 to 5 inclusive,
and between d 9 and 10. The correlation between differ-
ent days was at least moderate; and particularly strong
for Staph. aureus-induced proliferation, with the high-
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Figure 2. Matrix scatter plot showing correlation of individual
animal responses between days of culture for Staphylococcus aureus-
induced in vitro peripheral bloodmononuclear cell proliferation (1998,
1999, and 2000 cohorts only). All correlations are signiﬁcant, P <
0.001.
est correlation between consecutive days observed be-
tween d 4 and 5 (Table 1). The strong correlations
among days justiﬁed the assessment of proliferation on
d 4 only for the 2001 cohort.
Positive correlations were identiﬁed between Staph.
aureus-induced proliferation and control proliferation
on all days of culture, however, the positive correlation
decreased over time from 0.68 (P < 0.001) on d 2, to
0.27 (P < 0.001) on d 4, and to 0.24 (P < 0.001) on d 10
of culture. The analogous correlations for PHA-induced
and control proliferation were lower throughout: 0.19
(P < 0.001) on d 2, 0.34 (P < 0.001) on d 4, and 0.18 (P
< 0.01) on d 10. No signiﬁcant correlations were found
between Staph. aureus-induced proliferation and PHA-
induced proliferation on any of the days of in vitro
culture.
Correlations Between Test 1 and Test 2
(Same Individuals)
Staphylococcus aureus-induced and control prolifera-
tions were correlated on d 4 (0.30, 0.32, respectively, P
< 0.05) and 5 of culture (0.34, 0.38, respectively, P <
0.05) when the same animals were retested approxi-
Table 1. Correlations between consecutive days for the proliferation of peripheral blood mononuclear cell
(PBMC) proliferation induced by Staphylococcus aureus, phytohemagglutinin (PHA), and control in test 1.
All correlations are signiﬁcant (P < 0.001).
Correlation between culture days
PBMC proliferation d 2/d 3 d 3/d 4 d 4/d 5 d 5/d 9 d 9/d 10
Staph. aureus 0.862 0.931 0.968 0.729 0.958
PHA 0.641 0.758 0.885 0.508 0.868
Control 0.742 0.867 0.914 0.505 0.750
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mately 3 mo after the initial sampling (Table 2). This
result indicated that theStaph. aureus-induced and the
control proliferation on days of peak proliferation were
repeatable for samples taken up to 3 mo apart. A posi-
tive correlation (0.18, P < 0.1) for PHA-induced prolifer-
ation was seen on d 4 of culture. Day 4, therefore, was
identiﬁed as the most repeatable day of culture overall
for Staph. aureus-induced, PHA-induced, and control
PBMC proliferation and further validated the selection
of d 4 to assess the 2001 cohort.
REML Analyses
The results from the comparisons of test 1 and test
2 indicated that responses on d 4 and 5 were the most
likely to provide information upon the intrinsic attri-
butes of individual animals for Staph. aureus-induced
and control proliferation. However, PHA-induced re-
sponses, measured on d 4, although not statistically
signiﬁcant, showed a greater correlation than on d 5.
Results of REML analyses have therefore been pre-
sented for d 4 alone. This allowed more data to be in-
cluded and the correlations of variation on d 4 with the
variation observed at peak response (d 3 for PHA, d 5
for Staph. aureus) were high.
Control PBMC Proliferation
The control PBMC proliferation had a phenotypic
variance of 1.11 on the natural logarithmic scale, which
was indicative of the high coefﬁcient of variation (CV)
on the observed scale. Variation among sires, implicitly
additive genetic variation, formed a substantial compo-
nent of the total variance, with an estimated heritabil-
ity of 0.35 (SE 0.20; P < 0.001). There was signiﬁcant
interaction between breed-cross and the sex of the indi-
vidual (P < 0.05); for all breed-cross types, males had
a greatermeanproliferation in the control samples than
females, but this difference was greatest for the F2 and
least for the backcross Charolais. The design cannot
separate the inﬂuence of sex and the environment in
which the sex was kept due to confounding between
these ﬁxed effects.
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Table 2. Correlations among individuals for homologous assay days for test 1 (d 2, 3, 4, 5, 9, and 10) and
test 2 (repeat d (Rd) 2, 3, 4, 5, 9, and 10) when sampling was repeated after approximately 3 mo.
Correlations between test 1 and test 2
PBMC proliferation d 2/Rd 2 d 3/Rd 3 d 4/Rd 4 d 5/Rd 5 d 9/Rd 9 d 10/Rd 10
Staphylococcus aureus 0.124 0.017** 0.296* 0.346* 0.005 0.005
Phytohemagglutinin 0.125 0.120 0.178** 0.095 −0.016 0.136
Control 0.024 0.127 0.317* 0.384* 0.037 −0.027
*P < 0.005; **P < 0.10.
Staph. aureus-Induced PBMC Proliferation
The total phenotypic variance for the trait on the
natural logarithmic scale was 1.16 (SE = 0.09), indica-
tive of a large CV on the observed scale. There was no
signiﬁcant association of the type of breed-cross on the
levels of Staph. aureus-induced proliferation, but a sig-
niﬁcant association of sire was identiﬁed (P < 0.01) with
an estimate of trait heritability of 0.20 (SE = 0.14). In
general, the levels of Staph. aureus-induced prolifera-
tion increased with the age of the individual animal
assessed in the current study with a regression coefﬁ-
cient on the natural logarithmic scale of 0.0067 (SE =
0.0030;P < 0.05). On d 4 of culture in the whole data set,
an increase of 7 d in the age of the individual animals
sampled was associated with a 4.8% increase in the
levels of Staph. aureus-induced proliferation. A system-
atic reduction occurred in the levels of Staph. aureus-
induced proliferation between the sampling years (P <
0.001). There was no evidence for differences between
males and females, which were confounded with the
management. The level of control proliferation had a
positive signiﬁcant association with the levels of Staph.
aureus-induced PBMC proliferation with a regression
coefﬁcient of 0.42 (SE = 0.05;P < 0.001); this is distinctly
different from one that would be implicit in the analyses
of a stimulation index. Therefore, greater proliferation
was observed in samples with greater control values,
but a doubling of the control only increased the prolifer-
ation by 34%.
PHA-Induced PBMC Proliferation
The total phenotypic variance for the trait on a natu-
ral logarithmic scale was 0.83 (SE = 0.06), smaller than
for Staph. aureus-induced proliferation but still indica-
tive of a large CV on the observed scale. The sire was
signiﬁcantly associated with the levels of PHA-induced
PBMC proliferation (P < 0.01), with a trait heritability
of 0.18 (SE = 0.13), but there was no evidence of an
effect of the type of cross (P > 0.05). Although there
was no obvious trend, the year of birth was found to
inﬂuence PHA-induced proliferation (P < 0.001). In
common with Staph. aureus, there was no evidence for
Journal of Dairy Science Vol. 88, No. 7, 2005
a difference based on the confounded effects of sex and
management. In addition, control proliferation was sig-
niﬁcantly positively associated with the levels of PHA-
induced PBMC proliferation (P < 0.001), but the regres-
sion coefﬁcient 0.21 (SE = 0.04; P < 0.001) was lower
than for Staph. aureus-induced proliferation, with a
doubling of the control predicted to increase PHA-in-
duced proliferation by 16%.
DISCUSSION
The results of the REML analyses identiﬁed year of
birth and sire as the main signiﬁcant factors affecting
all 3 responsesmeasured:Staph. aureus-induced, PHA-
induced, and control proliferation. The control prolifer-
ation in the absence of antigen was itself a signiﬁcant
predictor of Staph. aureus- and PHA-induced prolifera-
tions, but age at sampling was only observed to inﬂu-
ence Staph. aureus proliferation. Previous studies
aimed at assessing immune function in cattle have gen-
erally been carried out on small numbers in females,
and in dairy rather than beef cattle (e.g., Weigel et al.,
1991; Detilleux et al., 1995). The current study involved
assessing a wide variety of PBMC-related immune re-
sponses in a large number of male and female animals,
with known and mixed genetic background, at approxi-
mately the same age.
The immune system has evolved in many complex
ways to deal with infection by pathogens (Engelhard,
1994). To be effective and reliable, multiple defense
systems must be available. Defense of the mammary
gland against mastitis-causing pathogens is mediated
by anatomical, cellular, and soluble protective factors;
speciﬁcally, innate and acquired immune factors, all
of which play vital roles in protecting the gland from
infectious disease (Sordillo et al., 1997). Despite the
presence of considerable numbers of immune cells in
the local mammary gland environment, it has been
shown that mammary gland immunity is generally
compromised when compared with systemic immunity
(Hurley et al., 1990). Previous studies identiﬁed a num-
ber of problems in assessing the function of cells isolated
frommilk (Paape et al., 2003). It was appropriate there-
fore to measure the response of immune cells isolated
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from the systemic circulation, due to the well-docu-
mented trafﬁcking of lymphocyte populations, which is
essential to adaptive immunity and is shared with the
peripheral system rather than the common mucosal
system (Kehrli and Harp, 2001). Assessment of the pro-
liferative responses of PBMC in cattle may provide an
indirect indicator of immune function of antigen-driven
cellular responses in the localmammary glands of cows,
and thus, an indicator of general immune competence
in bulls.
In the current study, a component of the variation in
Staph. aureus-induced proliferation was a repeatable
attribute of the animal, as there was a moderate corre-
lation between tests 1 and 2. It is possible that the
maturation of the juvenile immune system (Wilson et
al., 1996) will account for this relatively modest correla-
tion, as reﬂected in the relationship with age within
test 1, for Staph. aureus-induced proliferation. The pos-
sibility that this correlation resulted from increased
numbers of Staph. aureus-speciﬁc cells due to exposure
to this prevalent pathogen (Roberson et al., 1994; Cullor
and Tyler, 1996) argues that the Staph. aureus-induced
proliferation is merely the result of the environmental
exposure. The results from the genetic analyses in this
study suggest this is not the sole cause; nevertheless,
the correlations between days of culture within-assay
(i.e., between d 4 and d 5) and between-assay (i.e., test
1 and test 2) do provide support for Staph. aureus-
induced proliferation as a valid tool for assessment of
immune function.
Variation among individual cattle was observed in
the in vitro culture around peak proliferation for both
Staph. aureus-induced and PHA-induced cultures. Var-
ious factors can inﬂuence individual variability in the
intensity of a proliferative immune response induced
by a speciﬁc antigen including hormone levels (Hooper
et al., 1987), and the composition of the cellular subpop-
ulations in PBMC (Lutje and Black, 1991). Of potential
relevance to this paper, Park et al. (2004) identiﬁed a
link between the CD4:CD8 T-cell subset ratio in PBMC
and susceptibility to clinical mastitis. Variation in pro-
liferative response may be associated with the numbers
of memory T cells present in an individual, and thus,
may be regulated by prior exposure to that particular
antigen (Park et al., 1993; Wilson et al., 1996). Further
investigation of the cell subpopulations involved in the
proliferative responses described here is warranted.
Nonetheless, the genetic variation observed, identi-
ﬁed via the sire component of variance, supports the
hypothesis that a component of the variation is an in-
herent attribute of the animal. The heritability esti-
mates for all 3 traits are low to moderate, which is
consistent with the moderate correlations across time.
However, the magnitudes of the heritabilities are not
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a barrier to implementation within dairy improvement
schemes because progress has been achievedwith traits
of lower heritability.
The genes underlying the observed heritabilities may
include those of the major histocompatibility complex
(MHC), because variation in proliferative responsemay
also be associated with MHC haplotype. Glass et al.
(2000) suggested that cattle with duplicated DQ haplo-
types, located within the bovineMHC (bovine leukocyte
antigen complex, BoLA) class IIa region, may be able
to produce higher responses to antigens than cattlewith
single DQ haplotypes. Subsequently, Park et al. (2004)
concluded that susceptibility to mastitis in cattle was
associatedwithMHChaplotypes that have only a single
set of DQ genes. There is a considerable canon of pub-
lished studies reporting associations between bovine
MHC andmastitis, but even the largest study on bovine
MHC class I found inconsistent results within subsets
of the data (Mejdell et al., 1994). Nonetheless, theMHC
has been shown to be a major genetic component of
infectious or autoimmune disease resistance or suscep-
tibility in a variety of species (Klein, 1986; Tizard,
2000). Associations between bovineMHC class II alleles
and bull breeding have been shown with respect to
many conditions of dairy cattle including clinical masti-
tis, ketosis, retention of the placenta, and milk fever
(Lunden et al., 1991). A recent study in the Canadian
Holstein suggested the MHC II haplotype DRB3.2*23
conferred an increased susceptibility to mastitis, with
DRB3.2*16 conferring a decreased risk (Sharif et al.,
1998). The study by Sharif et al. (1998) graded the level
ofmastitis that occurred in these animals and identiﬁed
the pathogens responsible for the cases within the
grades. The identiﬁcation of the causative agent of dis-
eases is an essential aspect of the identiﬁcation of resis-
tant or susceptible BoLA alleles because the inﬂuence
of the BoLA alleles on immune function may differ be-
tween disease-causing pathogens (Dietz et al., 1997).
This is particularly important withmastitis wheremul-
tiple pathogens have been shown to be involved. Fur-
ther investigation ofMHChaplotypeswould allowmore
accurate assumptions of genetic correlations and con-
trol of immune function to be made.
The in vitro tests described here could provide indica-
tors of general immune competence, but no signiﬁcant
correlation was observed between Staph. aureus- and
PHA-induced responses. It therefore seems likely that
the genetic inﬂuences on the variation observed for
Staph. aureus- and PHA-induced proliferative re-
sponses are different, which may reﬂect the very differ-
ent processes involved in cell stimulation by mitogens
and antigens, as evidenced by the differential transcrip-
tional responses of PBMC to PHA and to a speciﬁc
antigen (Diaz-Mitoma et al., 2004).
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The immune system is affected by both environmen-
tal and genetic factors (Nguyen, 1984). The signiﬁcant
effect of sire and heritability estimates identiﬁed for
Staph. aureus-induced, PHA-induced, and control
PBMC proliferation in this study highlight the impor-
tance of genetic control of PBMC-related immune func-
tion. Whereas other studies by Tempelman et al. (2002)
and Saama et al. (2004) have identiﬁed a range of heri-
tability estimates for many general aspects of neutro-
phil and PBMC immunocompetence in dairy bulls, the
current study indicates the potential for identiﬁcation
of bulls whose progeny have superior PBMC responses
induced by speciﬁc immune stimuli, including to a bac-
terium that contributes to the pathogenesis of mastitis.
The long-termaim is to produce cattlewith high produc-
tion potential with sufﬁcient resistance to commonly
occurring diseases to permit fulﬁllment of their poten-
tial and maximize economic returns.
CONCLUSIONS
Staphylococcus aureus- and PHA-induced in vitro
assays were developed which identiﬁed signiﬁcant in-
ﬂuences on several aspects of PBMC-related immune
function in a crossbred population of cattle. Assessment
of potential immune responses to infection in 445 cross-
bred cattle identiﬁed variation among individual ani-
mals in their in vitro PBMC proliferative responses
induced by Staph. aureus and PHA, as well as variation
in control PBMC proliferation (PBMC and media only).
Statistical analyses identiﬁed control proliferation,
year of birth, age of the animal at sampling, and sire
to be of signiﬁcant inﬂuence. In particular, the sire-
inﬂuenced variation may predict PBMC-related im-
mune response to infection and allow improvements in
animal health and welfare by breeding animals with
increased resistance to important pathogens such as
Staph. aureus. This particular study may aid in the
interpretation of one aspect of a very complex system
of defense of the bovine mammary gland, which relies
on interactions between innate and acquired immune
parameters.
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